(Published in Part II, Section 3, Sub-section (ii) of
the Gazette of India, Extraordinary, dated the 30th November, 2007)
Government of India
Ministry of Chemicals and Fertilizers
National Pharmaceutical Pricing Authority
New Delhi, the 30th November, 2007
S.O. 2062(E)- In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (5) of the Table hereto annexed as the retail price/revised retail price in supersession earlier order dated 15.11.2007, exclusive of excise duty, sales taxes/VAT and local taxes, if any, and in column (6) equivalent MRP inclusive of excise duty, education cess, sales tax / VAT in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof; manufactured/imported by M/s. Novo Nordisk India Pvt. Ltd.
|Sl. No.||Name of the formulation||Pack Size||Existing Retail Price (Rs.)||Retail Price without Excise Duty Sales Tax /VAT and Local Tax, if any||Equivalent MRP* inclusive of all taxes (Rs.)|
Novorapid 100IU/ML 10ml Each ml containsSoluble insulin Aspart (Monocomponent
Insulin recombinanat DNA origin) 100IU
Batch No. SS61685/Qty100
*Subject to actual payment of Government levies/taxes, as applicable.
(a) The prices fixed are the maximum retail prices in column no. (6) (inclusive of excise duty, sales tax/VAT and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) The companies / manufacturers may added taxes only if they have paid actually to the Government on the price mentioned in the column (5). If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
(c) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.
(d) The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing /marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
(e) These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(f) The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.
F. No. 8(7)/2007/D.P./NPPA-Div.-II
Last Page Updated: 22-10-2018